David M. Shackleford
- Pharmaceutical Science top 2%
- Drug Solubulity and Delivery Systems 5
- Organic Chemistry top 5%
- Synthesis and Biological Evaluation 5
- Psychiatry and Mental health top 5%
- Toxicology top 5%
- Behavioral Neuroscience top 10%
-
- Research on Leishmaniasis Studies 11
- Malaria Research and Control 9
-
- Trypanosoma species research and implications 7
-
- Receptor Mechanisms and Signaling 7
-
- Analytical Chemistry and Chromatography 5
-
- HIV/AIDS drug development and treatment 5
- Co-authors
- Susan A. CharmanWilliam N. CharmanKaren L. WhiteChristopher J. H. PorterGlenn A. EdwardsErica K. SloanEliane AngstDavide Ferrari
- Journals
- SHILAP Revista de lepidopterología (2 papers)Immunity (1 paper)Scientific Reports (1 paper)
- Partner nations
- AustraliaSwitzerlandUnited States
In The Last Decade
David M. Shackleford
60 papers receiving 2.1k citations
Peers
Comparison fields: 5 of 111
- Pharmaceutical Science 236
- Organic Chemistry 714
- Psychiatry and Mental health 253
- Toxicology 55
- Behavioral Neuroscience 51
Countries citing papers authored by David M. Shackleford
This map shows the geographic impact of David M. Shackleford's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David M. Shackleford with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David M. Shackleford more than expected).
Fields of papers citing papers by David M. Shackleford
This network shows the impact of papers produced by David M. Shackleford. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David M. Shackleford. The network helps show where David M. Shackleford may publish in the future.
Co-authorship network
The 25 scholars most cited alongside David M. Shackleford, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2023 | 0 | |
| 3 | 2023 | 2 | |
| 4 | 2021 | 88 | |
| 5 | 2020 | 6 | |
| 6 | 2020 | 14 | |
| 7 | 2018 | 31 | |
| 8 | 2018 | 46 | |
| 9 | 2018 | 15 | |
| 10 | 2017 | 14 | |
| 11 | 2016 | 69 | |
| 12 | 2015 | 5 | |
| 13 | 2015 | 2 | |
| 14 | 2013 | 27 | |
| 15 | 2010 | 64 | |
| 16 | 2010 | 11 | |
| 17 | 2010 | 11 | |
| 18 | 2009 | 19 | |
| 19 | 2009 | 28 | |
| 20 | 2003 | 88 |
About David M. Shackleford
David M. Shackleford is a scholar working on Pharmaceutical Science, Parasitology and Public Health, Environmental and Occupational Health, having authored 64 papers that have together received 2.1k indexed citations. Recurring topics across this work include Research on Leishmaniasis Studies (11 papers), Malaria Research and Control (9 papers), Trypanosoma species research and implications (7 papers), Receptor Mechanisms and Signaling (7 papers), Analytical Chemistry and Chromatography (5 papers), Drug Solubulity and Delivery Systems (5 papers), HIV/AIDS drug development and treatment (5 papers) and Synthesis and Biological Evaluation (5 papers). The work is most often cited by research in Pharmaceutical Science (236 citations), Organic Chemistry (714 citations) and Psychiatry and Mental health (253 citations). David M. Shackleford has collaborated with scholars based in Australia, Switzerland and United States. Frequent co-authors include Susan A. Charman, William N. Charman, Karen L. White, Christopher J. H. Porter, Glenn A. Edwards, Erica K. Sloan, Eliane Angst, Davide Ferrari, Caroline P. Le and Matthew A. Pimentel. Their work appears in journals such as SHILAP Revista de lepidopterología, Immunity and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.